|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | -.--% |
|
+2.04% | +9.89% |
| 07-14 | PharmaCorp to Seek Acquisition Opportunities | CI |
| 07-14 | PharmaCorp Rx Closes C$11.5 Million Bought-Deal Offering of Share Units | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | 50x | - | 1.85x | 18.72x | 41.51x | 62.04M | ||
| -.--% | -.--% | 18.48x | 1.63x | 0.79x | 12.45x | 13.37x | 16.03B | ||
| 0.93% | 1.16% | 24.03x | 2.7x | 0.96x | 16.26x | 16.57x | 7.4B | ||
| 2.25% | 2.58% | 16.59x | 1.74x | 0.74x | 7.77x | 9.76x | 6.26B | ||
| 2.98% | 3.29% | 14.2x | 2.1x | 0.92x | 6.67x | 8.73x | 4.08B | ||
| 5.26% | 5.98% | 14.56x | 4.45x | 1.24x | 7.57x | 14.24x | 3.29B | ||
| 4.78% | 5.27% | 14.46x | 2.71x | 0.6x | 4.77x | 7.88x | 3.18B | ||
| 4.22% | 4.63% | 15.19x | 6.87x | 0.92x | 6.92x | 9.62x | 3.12B | ||
| 1.92% | 2.33% | 21.39x | 3.74x | 0.62x | 7.93x | 12.99x | 1.55B | ||
| 0.02% | -.--% | -117.71x | 2.63x | 0.44x | 16.06x | 69.13x | 1.45B | ||
| 4.06% | 4.57% | 12.49x | 0.89x | 0.3x | 2.9x | 5.97x | 992M | ||
| 5.76% | 5.57% | 14.51x | 2.4x | 0.85x | 6.91x | 14.88x | 919M | ||
| 1.36% | 1.97% | 26.28x | 7.17x | 0.95x | 12.97x | 20.11x | 801M | ||
| Average | 2.8% | 3.11% | 9.57x | 3.25x | 0.86x | 9.84x | 18.83x | 3.78B | |
| Weighted average by Cap. | 1.88% | 2.12% | 14.02x | 2.62x | 0.83x | 10.46x | 14.13x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















